These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32964459)

  • 1. A missense mutation sheds light on a novel structure-function relationship of RANKL.
    Qiu H; Qin A; Cheng T; Chim SM; Smithers L; Chen K; Song D; Liu Q; Zhao J; Wang C; Teguh D; Zhang G; Tickner J; Vrielink A; Pavlos NJ; Xu J
    J Cell Physiol; 2021 Apr; 236(4):2800-2816. PubMed ID: 32964459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activation.
    Cheng T; Pavlos NJ; Wang C; Tan JW; Lin JM; Cornish J; Zheng MH; Xu J
    Mol Endocrinol; 2009 Jan; 23(1):35-46. PubMed ID: 19008464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF.
    Douni E; Rinotas V; Makrinou E; Zwerina J; Penninger JM; Eliopoulos E; Schett G; Kollias G
    Hum Mol Genet; 2012 Feb; 21(4):784-98. PubMed ID: 22068587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand.
    Xu J; Tan JW; Huang L; Gao XH; Laird R; Liu D; Wysocki S; Zheng MH
    J Bone Miner Res; 2000 Nov; 15(11):2178-86. PubMed ID: 11092398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL.
    Jang Y; Sohn HM; Ko YJ; Hyun H; Lim W
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel RANKL DE-loop mutants antagonize RANK-mediated osteoclastogenesis.
    Wang Y; van Assen AHG; Reis CR; Setroikromo R; van Merkerk R; Boersma YL; Cool RH; Quax WJ
    FEBS J; 2017 Aug; 284(15):2501-2512. PubMed ID: 28627025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.
    Guerrini MM; Sobacchi C; Cassani B; Abinun M; Kilic SS; Pangrazio A; Moratto D; Mazzolari E; Clayton-Smith J; Orchard P; Coxon FP; Helfrich MH; Crockett JC; Mellis D; Vellodi A; Tezcan I; Notarangelo LD; Rogers MJ; Vezzoni P; Villa A; Frattini A
    Am J Hum Genet; 2008 Jul; 83(1):64-76. PubMed ID: 18606301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of bone resorption and formation by RANKL reverse signalling.
    Ikebuchi Y; Aoki S; Honma M; Hayashi M; Sugamori Y; Khan M; Kariya Y; Kato G; Tabata Y; Penninger JM; Udagawa N; Aoki K; Suzuki H
    Nature; 2018 Sep; 561(7722):195-200. PubMed ID: 30185903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway.
    Doss HM; Samarpita S; Ganesan R; Rasool M
    Life Sci; 2018 Aug; 207():284-295. PubMed ID: 29908722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.
    Warren JT; Zou W; Decker CE; Rohatgi N; Nelson CA; Fremont DH; Teitelbaum SL
    J Cell Biochem; 2015 Nov; 116(11):2476-83. PubMed ID: 25864714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
    Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longan fruit increase bone mineral density in zebrafish and ovariectomized rat by suppressing RANKL-induced osteoclast differentiation.
    Son Y; Lee EM; Lee DY; Lee JH; Oh S
    Phytomedicine; 2019 Jun; 59():152910. PubMed ID: 30978650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J; Jing Z; Hu W; Yu J; Cui X
    Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boldine isolated from Litsea cubeba inhibits bone resorption by suppressing the osteoclast differentiation in collagen-induced arthritis.
    Zhao H; Xu H; Qiao S; Lu C; Wang G; Liu M; Guo B; Tan Y; Ju D; Xiao C
    Int Immunopharmacol; 2017 Oct; 51():114-123. PubMed ID: 28826044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.
    Yao Z; Lei W; Duan R; Li Y; Luo L; Boyce BF
    J Biol Chem; 2017 Jun; 292(24):10169-10179. PubMed ID: 28438834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.
    Luo J; Yang Z; Ma Y; Yue Z; Lin H; Qu G; Huang J; Dai W; Li C; Zheng C; Xu L; Chen H; Wang J; Li D; Siwko S; Penninger JM; Ning G; Xiao J; Liu M
    Nat Med; 2016 May; 22(5):539-46. PubMed ID: 27064449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy-linked FYVE containing protein WDFY3 interacts with TRAF6 and modulates RANKL-induced osteoclastogenesis.
    Wu DJ; Gu R; Sarin R; Zavodovskaya R; Chen CP; Christiansen BA; Zarbalis KS; Adamopoulos IE
    J Autoimmun; 2016 Sep; 73():73-84. PubMed ID: 27330028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.